"In the U.S., Latinos are disproportionately affected by the COVID-19 pandemic. A critical step to reduce the spread of COVID-19 is diagnostic testing," write scholar Luz Garcini and co-authors. This research article identifies the barriers and facilitators that must be addressed in order to implement accessible, effective testing.
Luz Maria Garcini, Tommy Tam Pham, Arlynn Ambriz, Sarah Lill, Joel TsevatOctober 31, 2021
This study finds that Maryland's all-payer model for healthcare comparatively lowered the risk of complications from surgery, as well as reducing increases in associated costs.
Anaeze C. Offodile II, Oluseyi Aliu, Andrew W. P. Lee, Jonathan E. Efron, Robert S. D. Higgins, Charles ButlerSeptember 28, 2021
The international Human Microbiome Project trumpeted the coming of age of the field of metagenomics, the study of entire communities of microbes and their contributions to health and disease. In parallel, the field of metabolomics emerged as the systematic, nonbiased analysis of all low-molecular-weight small molecules, or metabolites, produced by a system in response to an environmental stimulus. These fields have enabled discoveries pertinent to a number of human conditions — namely, acute gastroenteritis, antibiotic-associated diarrhea, inflammatory bowel disease, irritable bowel syndrome, liver disease, undernutrition and obesity — and have begun to shed new light on multiple aspects of the neglected tropical diseases.
In a genuine effort to protect patients from adverse events, regulatory burdens and research rigidity in clinical trials have increased to a point at which such protection is outweighing the benefits, and actually harming patients who are unable to be involved in clinical trials.
Hagop M. Kantarjian, David J. Stewart, Leonard A. ZwellingJune 6, 2013